Exploring the Importance of Differential Expression of Autophagy Markers in Term Placentas from Late-Onset Preeclamptic Pregnancies

Luis M. Garcia-Puente,Cielo García-Montero,Oscar Fraile-Martinez,Julia Bujan,Juan A. De León-Luis,Coral Bravo,Patrocinio Rodríguez-Benitez,Laura López-González,Raul Díaz-Pedrero,Melchor Álvarez-Mon,Natalio García-Honduvilla,Miguel A. Saez,Miguel A. Ortega
DOI: https://doi.org/10.3390/ijms25042029
IF: 5.6
2024-02-08
International Journal of Molecular Sciences
Abstract:Preeclampsia (PE) is a serious hypertensive disorder affecting 4–5% of pregnancies globally, leading to maternal and perinatal morbidity and mortality and reducing life expectancy in surviving women post-gestation. Late-onset PE (LO-PE) is a clinical type of PE diagnosed after 34 weeks of gestation, being less severe than the early-onset PE (EO-PE) variant, although both entities have a notable impact on the placenta. Despite the fact that most studies have focused on EO-PE, LO-PE does not deserve less attention since its prevalence is much higher and little is known about the role of the placenta in this pathology. Via RT-qPCR and immunohistochemistry methods, we measured the gene and protein expressions of several macroautophagy markers in the chorionic villi of placentas from women who underwent LO-PE (n = 68) and compared them to normal pregnancies (n = 43). We observed a markedly distinct expression pattern, noticing a significant drop in NUP62 expression and a considerable rise in the gene and protein expressions of ULK1, ATG9A, LC3, ATG5, STX-17, and LAMP-1 in the placentas of women with LO-PE. A major induction of autophagic processes was found in the placental tissue of patients with LO-PE. Abnormal signaling expression of these molecular patterns in this condition aids in the understanding of the complexity of pathophysiology and proposes biomarkers for the clinical management of these patients.
biochemistry & molecular biology,chemistry, multidisciplinary
What problem does this paper attempt to address?